PUBLISHER: Market Research Future | PRODUCT CODE: 1607755
PUBLISHER: Market Research Future | PRODUCT CODE: 1607755
Global Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032
The market for Nicotine Oral Dissolvable Thin Films was estimated to be worth USD 0.10 billion by 2023. The Nicotine Oral Dissolvable Thin Films Market is expected to increase from USD 0.11 billion in 2024 to USD 0.15 billion by 2032, with a compound yearly growth rate (CAGR) of 3.86% over the forecast period (2024-2032).
Significant demand for nicotine oral dissolvable thin films is being driven by growing efforts to quit smoking, which is accelerating market growth in a variety of ways. People are actively encouraged to quit smoking or reduce their nicotine consumption through public health campaigns and government initiatives, such as those run by the Office on Smoking and Health (OSH). Programs targeted at lowering tobacco use help in these efforts by providing tools and resources for implementing effective stop strategies.
Furthermore, the advantages of oral thin film (OTF) technology are important factors propelling the global nicotine oral dissolvable thin film market. Here are a few significant advantages that contribute to market expansion. OTFs dissolve quickly in the mouth and do not require water, making them a simple and portable form of nicotine delivery. Users can use them discreetly at any time and from any place.
Market Segment insights
The Nicotine Oral Dissolvable Thin Films Market is divided into three segments based on strength: 1mg, 2mg, and Others.
The Market has been divided into two sections based on the way of administration.
The Nicotine Oral Dissolvable Thin Films Market is divided into two age groups: adults and adolescents.
The market has been divided into two segments based on the sales channel: online and offline.
Regional insights
The North America Nicotine Oral Dissolvable Thin Films Market was worth USD 31.20 million in 2023, and it is expected to increase at a CAGR of 3.86% over the forecast period. North America is further divided into the United States and Canada. The North American nicotine oral dissolvable thin films market is expanding rapidly, driven by increased awareness of smoking cessation aids and the rising prevalence of smoking-related health conditions.
The Europe Nicotine Oral Dissolvable Thin Films Market was worth USD 44.48 million in 2023, and it is expected to increase at a CAGR of 3.46% over the forecast period. The European nicotine oral dissolvable thin films market is expected to increase significantly in the coming years, owing to the increasing popularity of nicotine oral dissolvable thin films and the existence of industry players.
The Asia-Pacific Nicotine Oral Dissolvable Thin Films Market was worth USD 20.74 million in 2023, and it is expected to increase at a CAGR of 4.77% over the forecast period. The Asia-Pacific nicotine oral dissolvable thin films market is expanding rapidly due to rising health awareness, urbanization, and high smoking rates in countries such as China, South Korea, India, and Japan.
Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) are among the market's key players.